Related Experiment Videos
Reversible severe hereditary hemochromatotic cardiomyopathy
1Department of Medicine, University of Ottawa, Ontario. tmadani@kaau.edu.sa
The Canadian Journal of Cardiology
|April 1, 1997
Abstract:
Two cases of severe hereditary hemochromatotic cardiomyopathy are reported. Both patients responded remarkably well to treatment and are leading a normal life requiring no cardiac medications, following small volume phlebotomies for two years combined, in the first three and six months of treatment, with subcutaneous deferoxamine mesylate.